MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BIO.B — Bio-Rad Laboratories, Inc. Class B

NYSE

Bio-Rad Laboratories, Inc. Class B

CompareBack to Screener
$365.08
+28.08(+8.33%)
O
365.08
H
365.08
L
365.08
V
103.15
⏱️ End-of-day dataAs of Aug 20, 2026

Chart

About BIO.B

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

IndustryLABORATORY ANALYTICAL INSTRUMENTS
SectorNot available
IPO DateJan 1, 1900
Employees7,450
Stock ExchangeNYSE
Ticker SymbolBIO.B

Key Financial Statistics

Market CapN/A
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$244.54 - $365.08
52-Week Avg Volume68.347
VWAP$367.84
Transactions24
Total Recorded Bars6,747 days